Individuals Stopping Slimming Medications Regain Weight at a Quadrupled Rate Than Dieters

New research indicates that individuals who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro may regain lost weight far faster than those who end conventional diet and exercise plans.

Findings released in a prominent health publication points out that while obese people can lose substantial amounts of their body weight while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month after stopping.

"Individuals purchasing these treatments should be cognizant of the danger of rapid weight regain when the medication ends," stated lead investigator Dr. Susan Jebb.

This pace of recovery suggests a return to starting mass in about 18 months.

Weighing Approaches

The study, which reviewed dozens of studies involving thousands of patients, contrasted the effects of these new drugs with other pills.

The team note that people who lose weight through dieting generally have a less rapid creep back—perhaps 0.1 kg a month—after stopping.

Understanding the Rapid Rebound

Doctors propose the mode of action of the injections explains the accelerated rebound.

GLP-1 drugs imitate a natural hormone called GLP-1, which controls hunger.

"Long-term administration of the hormone levels far above than the body's typical production may cause the system to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this medication leads to appetite is uncontrolled, making binge eating much more probable."

An Ongoing Issue?

The NHS advise the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

Professionals contend that, due to the significant potential of relapse, the therapy might need to be life-long.

This view is echoed by drug manufacturers, who note that the findings "emphasize the long-term nature of obesity," comparing it to managing diseases like diabetes.

User Testimonies

Users who have stopped the medication describe a powerful return of hunger.

"It was like a switch that goes on and you're instantly extremely hungry," said a patient.

This difficulty is exacerbated if patients have not developed permanent lifestyle or habit changes during treatment.

Significant Use

Figures show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.

• Adoption is greater among women compared to males.
• The 40s and 50s demographic shows the highest level of interest.
• A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, experts emphasize that while these medications are effective tools for weight loss, they are not a standalone cure and lasting health benefits hinges on combined behavioural management.